CN101066291A - 一种温阳益气、养心安神的中药组合物及其制备方法 - Google Patents
一种温阳益气、养心安神的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN101066291A CN101066291A CNA2007100350700A CN200710035070A CN101066291A CN 101066291 A CN101066291 A CN 101066291A CN A2007100350700 A CNA2007100350700 A CN A2007100350700A CN 200710035070 A CN200710035070 A CN 200710035070A CN 101066291 A CN101066291 A CN 101066291A
- Authority
- CN
- China
- Prior art keywords
- parts
- add
- filtrate
- bee pollen
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 52
- 239000003814 drug Substances 0.000 title claims abstract description 42
- 238000010792 warming Methods 0.000 title claims abstract description 14
- 238000002360 preparation method Methods 0.000 claims abstract description 26
- 230000002936 tranquilizing effect Effects 0.000 claims abstract description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 88
- 239000000706 filtrate Substances 0.000 claims description 62
- 239000007788 liquid Substances 0.000 claims description 60
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 50
- 229940038481 bee pollen Drugs 0.000 claims description 45
- 239000000341 volatile oil Substances 0.000 claims description 38
- 238000003756 stirring Methods 0.000 claims description 29
- 238000005303 weighing Methods 0.000 claims description 15
- 108090000790 Enzymes Proteins 0.000 claims description 13
- 102000004190 Enzymes Human genes 0.000 claims description 13
- 230000006837 decompression Effects 0.000 claims description 13
- 239000002994 raw material Substances 0.000 claims description 13
- 238000004064 recycling Methods 0.000 claims description 13
- 239000012535 impurity Substances 0.000 claims description 11
- 239000002671 adjuvant Substances 0.000 claims description 7
- 229940079593 drug Drugs 0.000 claims description 7
- 239000002552 dosage form Substances 0.000 claims description 4
- 239000007924 injection Substances 0.000 claims description 2
- 238000002347 injection Methods 0.000 claims description 2
- 239000006211 transdermal dosage form Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 8
- 230000036039 immunity Effects 0.000 abstract description 7
- 241000893536 Epimedium Species 0.000 abstract description 2
- 235000018905 epimedium Nutrition 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 230000000747 cardiac effect Effects 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 208000019553 vascular disease Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 39
- 241000256836 Apis Species 0.000 description 24
- TZJALUIVHRYQQB-XFDQAQKOSA-N Icariin Natural products O(C)c1ccc(C2=C(O[C@H]3[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)C(=O)c3c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O4)c(C/C=C(\C)/C)c3O2)cc1 TZJALUIVHRYQQB-XFDQAQKOSA-N 0.000 description 15
- TZJALUIVHRYQQB-XLRXWWTNSA-N icariin Chemical compound C1=CC(OC)=CC=C1C1=C(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)C(=O)C2=C(O)C=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-XLRXWWTNSA-N 0.000 description 15
- TZJALUIVHRYQQB-UHFFFAOYSA-N icariine Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(C)O2)O)C(=O)C2=C(O)C=C(OC3C(C(O)C(O)C(CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-UHFFFAOYSA-N 0.000 description 15
- 238000000605 extraction Methods 0.000 description 13
- 239000000284 extract Substances 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 230000007812 deficiency Effects 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 208000029078 coronary artery disease Diseases 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- 238000001959 radiotherapy Methods 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 6
- 210000000265 leukocyte Anatomy 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 238000001256 steam distillation Methods 0.000 description 6
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 5
- 238000002512 chemotherapy Methods 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- 206010020772 Hypertension Diseases 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 206010008118 cerebral infarction Diseases 0.000 description 4
- 208000026106 cerebrovascular disease Diseases 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 230000000630 rising effect Effects 0.000 description 4
- 241000208340 Araliaceae Species 0.000 description 3
- 206010006187 Breast cancer Diseases 0.000 description 3
- 208000026310 Breast neoplasm Diseases 0.000 description 3
- 208000007443 Neurasthenia Diseases 0.000 description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 201000008275 breast carcinoma Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 235000008434 ginseng Nutrition 0.000 description 3
- 208000013403 hyperactivity Diseases 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 229940109850 royal jelly Drugs 0.000 description 3
- 238000004062 sedimentation Methods 0.000 description 3
- 241000256844 Apis mellifera Species 0.000 description 2
- 201000006474 Brain Ischemia Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010008120 Cerebral ischaemia Diseases 0.000 description 2
- 206010008342 Cervix carcinoma Diseases 0.000 description 2
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 2
- 241001069921 Libido Species 0.000 description 2
- 206010025323 Lymphomas Diseases 0.000 description 2
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 2
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 2
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 229940041181 antineoplastic drug Drugs 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- 201000010881 cervical cancer Diseases 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 201000002313 intestinal cancer Diseases 0.000 description 2
- 201000002364 leukopenia Diseases 0.000 description 2
- 231100001022 leukopenia Toxicity 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 201000011216 nasopharynx carcinoma Diseases 0.000 description 2
- 230000036299 sexual function Effects 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- XDBMTQVSHNQIFU-UHFFFAOYSA-N 2-(2-ethoxy-2-oxo-1-phenylethyl)-1,3-thiazolidin-3-ium-4-carboxylate Chemical compound C=1C=CC=CC=1C(C(=O)OCC)C1NC(C(O)=O)CS1 XDBMTQVSHNQIFU-UHFFFAOYSA-N 0.000 description 1
- 108700005239 3-Hydroxyacyl-CoA Dehydrogenase Deficiency Proteins 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 201000006306 Cor pulmonale Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 241000608867 Leucogenes Species 0.000 description 1
- 208000007433 Lymphatic Metastasis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 239000008118 PEG 6000 Substances 0.000 description 1
- 241001307210 Pene Species 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000004186 Pulmonary Heart Disease Diseases 0.000 description 1
- 208000020764 Sensation disease Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940127086 antineoplastic adjuvant Drugs 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- -1 filter Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000009592 kidney function test Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000000388 leucogen effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000005015 mediastinal lymph node Anatomy 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011127 radiochemotherapy Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 208000012201 sexual and gender identity disease Diseases 0.000 description 1
- 208000015891 sexual disease Diseases 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
加水量(倍) | 3 | 4 | 5 | 6 | 7 |
收油率(%) | 2.45% | 2.48% | 2.54% | 2.50% | 2.48% |
实验号 | 投料量 | 1小时 | 2小时 | 3小时 | 4小时 |
1 | 300g | 2.41% | 2.54% | 2.54% | 2.55% |
2 | 300g | 2.43% | 2.56% | 2.57% | 2.58% |
3 | 300g | 2.38% | 2.51% | 2.53% | 2.54% |
提取次数 | 第一次 | 第二次 | 第三次 |
淫羊藿苷含量 | 0.87mg/ml | 0.081mg/ml | 0.018mg/ml |
淫羊藿苷收率 | 90.2% | 5.1% | 1.1% |
提取时间 | 0.5小时 | 1小时 | 1.5小时 |
淫羊藿苷含量 | 0.078mg/ml | 0.082mg/ml | 0.083mg/ml |
加水量 | 3倍 | 4倍 | 5倍 |
滤液体积 | 850ml | 1110ml | 1400ml |
淫羊藿苷含量 | 0.081mg/ml | 0.066mg/ml | 0.047mg/ml |
淫羊藿苷总含量 | 69.7mg | 69.9mg | 68.6mg |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2007100350700A CN100471488C (zh) | 2007-06-06 | 2007-06-06 | 一种温阳益气、养心安神的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2007100350700A CN100471488C (zh) | 2007-06-06 | 2007-06-06 | 一种温阳益气、养心安神的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101066291A true CN101066291A (zh) | 2007-11-07 |
CN100471488C CN100471488C (zh) | 2009-03-25 |
Family
ID=38879071
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2007100350700A Active CN100471488C (zh) | 2007-06-06 | 2007-06-06 | 一种温阳益气、养心安神的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100471488C (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109170898A (zh) * | 2018-10-19 | 2019-01-11 | 太和县三九药业有限公司 | 一种增强免疫力玛咖粉西洋参淫羊藿胶囊 |
CN109198629A (zh) * | 2018-10-19 | 2019-01-15 | 太和县三九药业有限公司 | 一种补肾、益精血、增强免疫力的人参淫羊藿软胶囊 |
-
2007
- 2007-06-06 CN CNB2007100350700A patent/CN100471488C/zh active Active
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109170898A (zh) * | 2018-10-19 | 2019-01-11 | 太和县三九药业有限公司 | 一种增强免疫力玛咖粉西洋参淫羊藿胶囊 |
CN109198629A (zh) * | 2018-10-19 | 2019-01-15 | 太和县三九药业有限公司 | 一种补肾、益精血、增强免疫力的人参淫羊藿软胶囊 |
Also Published As
Publication number | Publication date |
---|---|
CN100471488C (zh) | 2009-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1957724A (zh) | 降脂减肥茶及其制备方法 | |
CN1840166A (zh) | 温胆汤现代中药口服制剂及其生产方法 | |
CN1228074C (zh) | 治疗免疫功能低下或紊乱的中药 | |
CN1429612A (zh) | 三十六味消渴胶囊 | |
CN1293898C (zh) | 治疗病毒性肝炎的药物组合物的制备方法 | |
CN100471488C (zh) | 一种温阳益气、养心安神的中药组合物及其制备方法 | |
CN1183841C (zh) | 一种抗疲劳男士保健茶及其制备方法 | |
CN112494569B (zh) | 一种提高免疫力的中药组合物及其制备方法和用途 | |
CN1261138C (zh) | 增强儿童免疫能力的药物及其制备方法 | |
CN1772257A (zh) | 三七脂肝制剂及其制备方法 | |
CN1264543C (zh) | 一种治疗婴幼儿腹泻的药物及其制备方法 | |
CN1679658A (zh) | 一种治疗艾兹病的中药制剂及其加工方法 | |
CN1232283C (zh) | 治疗冠心病心绞痛的中药 | |
CN1973850A (zh) | 一种治疗过敏性鼻炎的药物组合物及其制备方法 | |
CN1947767A (zh) | 一种治疗及预防小儿智力低下药物及其制备方法 | |
CN1541691A (zh) | 治疗急性黄疸肝炎的中药及其制备方法 | |
CN1899387A (zh) | 防治小儿惊厥的药物及其制备方法 | |
CN1253188C (zh) | 一种治疗高血压的药物及其制备方法 | |
CN1666658A (zh) | 一种适用于糖尿病病人的保健品及其生产方法 | |
CN1274353C (zh) | 一种防治儿童疳积的药物及其制备方法 | |
CN1304045C (zh) | 症痛康颗粒及其制备方法 | |
CN102836315A (zh) | 一种预防调理转归肿瘤的中药组合物及其制备方法 | |
CN1333044A (zh) | 消渴降糖宝 | |
CN1824075A (zh) | 一种治疗偏头痛的药物组合物及其应用 | |
CN1263490C (zh) | 一种助阳药及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: 410005, Hunan, Changsha province Furong Road, No. 368 BOBO world city CTA wealth center, 24 floor Patentee after: HUNAN JIUDIAN PHARMACEUTICAL CO., LTD. Address before: 410011, Hunan, Changsha province Furong South Road section 368 BOBO world city CTA wealth center, 24 floor Patentee before: Hunan Jiudian Pharmaceutical Co., Ltd. |
|
CP02 | Change in the address of a patent holder |
Address after: 410205 8th floor, building A1, Lugu science and Technology Industrial Park, Wukuang, No.28, Ludian Road, Yuelu District, Changsha City, Hunan Province Patentee after: HUNAN JIUDIAN PHARMACEUTICAL Co.,Ltd. Address before: 410005, Hunan, Changsha province Furong Road, No. 368 BOBO world city CTA wealth center, 24 floor Patentee before: HUNAN JIUDIAN PHARMACEUTICAL Co.,Ltd. |
|
CP02 | Change in the address of a patent holder | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200820 Address after: 410205 8th floor, building A1, Lugu science and Technology Industrial Park, Wukuang, No.28, Ludian Road, Yuelu District, Changsha City, Hunan Province Co-patentee after: HUNAN PUDAO MEDICAL TECHNOLOGY Co.,Ltd. Patentee after: HUNAN JIUDIAN PHARMACEUTICAL Co.,Ltd. Address before: 410205 8th floor, building A1, Lugu science and Technology Industrial Park, Wukuang, No.28, Ludian Road, Yuelu District, Changsha City, Hunan Province Patentee before: HUNAN JIUDIAN PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhu Zhihong Inventor after: Xiang Bo Inventor after: Lu Shang Inventor after: Yang Jing Inventor before: Zhu Zhihong Inventor before: Yang Jing |
|
CB03 | Change of inventor or designer information | ||
CP02 | Change in the address of a patent holder |
Address after: No.1, Jiankang Avenue, Liuyang Biomedical Park, Liuyang City, Changsha City, Hunan Province Patentee after: HUNAN JIUDIAN PHARMACEUTICAL Co.,Ltd. Patentee after: HUNAN PUDAO MEDICAL TECHNOLOGY Co.,Ltd. Address before: 410205 8th floor, building A1, Lugu science and Technology Industrial Park, Wukuang, No.28, Ludian Road, Yuelu District, Changsha City, Hunan Province Patentee before: HUNAN JIUDIAN PHARMACEUTICAL Co.,Ltd. Patentee before: HUNAN PUDAO MEDICAL TECHNOLOGY Co.,Ltd. |
|
CP02 | Change in the address of a patent holder |